Legal Representation
Attorney
Marjorie Witter Norman
USPTO Deadlines
Application History
17 eventsDate | Code | Type | Description |
---|---|---|---|
Jul 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 5, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 3, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 3, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 3, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Mar 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Feb 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 6, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Nov 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Nov 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Nov 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 17, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Pharmaceutical services, namely, monitoring of pharmaceuticals, biopharmaceuticals, and plasma products prescribed for patients and assessing side effects, mitigation strategies, response to therapy, and laboratory results for business purposes
First Use Anywhere:
Dec 18, 2018
First Use in Commerce:
Dec 18, 2018
Class 036
Providing counseling and consulting in the field of healthcare insurance benefits; providing patient advocacy services regarding healthcare insurance prior approvals, reauthorizations, claims, appeals, and reimbursements in the nature of insurance administration services
First Use Anywhere:
Dec 18, 2018
First Use in Commerce:
Dec 18, 2018
Class 039
Delivery of pharmaceuticals, biopharmaceuticals, and plasma products to homes
First Use Anywhere:
Dec 18, 2018
First Use in Commerce:
Dec 18, 2018
Class 044
Providing medical information; dispensing of pharmaceuticals, namely, providing patients with pharmaceuticals, biopharmaceuticals, and plasma products; medical services, namely, coordinating in-home nursing care and infusion in the nature of intravenous (IV) medication therapy services for patients; prescription refill reminder services; providing online information in the field of health and medicine, namely, information regarding medical prescriptions, therapies, and treatments, to patients and medical staff; Providing online information in the field of health and medicine, namely, information regarding pharmaceutical and therapeutic treatments for infusion patients; Providing online information in the field of health and medicine, namely, information regarding nursing care for infusion patients; monitoring pharmaceuticals, biopharmaceuticals, and plasma products prescribed for patients and assessing side effects, mitigation strategies, response to therapy, and laboratory results in the nature of pharmaceutical consultation
First Use Anywhere:
Dec 18, 2018
First Use in Commerce:
Dec 18, 2018
Additional Information
Design Mark
The mark consists of the word "NUFACTOR" in small-case stylized letters above the words "A SPECIALTY INFUSION COMPANY" in large-case stylized letters.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
035
036
039
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"A SPECIALTY INFUSION COMPANY"